Aspirin Treatment for Small Unruptured InTracranial Aneurysms With Ischemic cereBrovascuLar diseasE

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 824 participants.

Also called NCT05907902

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 824 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05907902
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05907902. Randomized; single masking; primary purpose treatment. Start 2023-07-01 (anticipated); primary completion 2025-07-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Aspirin Treatment for Small Unruptured InTracranial Aneurysms With Ischemic cereBrovascuLar diseasE
Acronym
AT-SUITABLE
Condition
Intracranial Aneurysm
Condition
Cerebrovascular Disease
Intervention (Drug)
Aspirin Enteric-coated Tablets
Lead sponsor
Beijing Tiantan Hospital (class: other)

Record details

Record id
cardio:ct-nct05907902
Content hash
1b9c4eca1959c3e6b9f3e5d933f1086a19f2277b736f1e2bf2a6c6fe850a82e4